Table 3 Stratification of prognostic factors by HBV status
Clinical factor | Chronic hepatitis | P value | All makers negative | P value | The anti-HBs positive |
|---|---|---|---|---|---|
Total | 37 | 23 | 21 | ||
Age | 0.051 | 0.690 | |||
≤ 60 y | 24 (67.2%) | 9 (39.1%) | 7 (29.2%) | ||
> 60 y | 13 (32.8%) | 14 (60.9%) | 14 (70.8%) | ||
CA19-9 | 0.047 | 0.622 | |||
≤ 200 U/ml | 21 (56.8%) | 7 (30.4%) | 5 (23.8%) | ||
> 200 U/ml | 16 (43.2%) | 16 (69.6%) | 16 (76.2%) | ||
TIBL | 0.051 | 0.131 | |||
≤ 20 μmol/L | 24 (64.9%) | 9 (39.1%) | 13 (61.9%) | ||
> 20 μmol/L | 13 (35.1%) | 14 (60.9%) | 8 (38.1%) | ||
GGT | 0.496 | 0.870 | |||
≤ 64 U/L | 11 (29.7%) | 5 (21.7%) | 5 (23.8%) | ||
> 64 U/L | 26 (70.3%) | 18 (78.3%) | 16 (76.2%) | ||
ALP | 0.001 | 0.202 | |||
≤ 119 U/L | 16 (43.2%) | 3 (13.0%) | 6 (28.6%) | ||
> 119 U/L | 11 (56.8%) | 20 (87.0%) | 15 (71.4%) | ||
Lymphatic metastasis | 0.001 | 0.862 | |||
No | 20 (54.0%) | 6 (26.8%) | 5 (23.8%) | ||
Yes | 17 (46.0%) | 17 (73.2%) | 16 (76.2%) | ||
Operation pattern | 0.518 | 0.717 | |||
Radical | 24 (64.9%) | 13 (56.5%) | 13 (61.9%) | ||
Palliative | 13 (35.1%) | 10 (43.5%) | 8 (38.1%) | ||
Intrahepatic metastasis | 0.811 | 0.820 | |||
No | 23 (62.1%) | 15 (65.2%) | 13 (61.9%) | ||
Yes | 14 (37.9%) | 8 (34.8%) | 8 (38.1%) | ||
Adjuvant chemotherapy | 8 (21.6%) | 5 (21.7%) | 5 (23.8%) |